Sphingomyelin synthase 2 promotes the stemness of breast cancer cells via modulating NF-κB signaling pathwayHaizhan Feng(Zhujiang Hospital), Fujun Shi(Zhujiang Hospital)Journal of Cancer Research and Clinical OncologyJanuary 29, 202410.1007/s00432-023-05589-yCited by 5SaveCiteExport RISWatch citationsRelated PapersSphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin|Cell Death and Disease|2019|92